Gleason, C., D. Norton, E. Anderson, M. Wahoske, D. Washington, E. Umucu, R. Koscik, N. Dowling, S. Johnson, C. Carlsson, S. Asthana, and D. Alzheimer’s. “Cognitive Variability Predicts Incident Alzheimer’s Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker.”. Journal of Alzheimer’s Disease : JAD, Vol. 61, no. 1, 2018, pp. 79-89.
Alzheimer’s disease (AD) biomarkers are emerging as critically important for disease detection and monitoring. Most biomarkers are obtained through invasive, resource-intense procedures. A cognitive marker, intra-individual cognitive variability (IICV) may provide an alternative or adjunct marker of disease risk for individuals unable or disinclined to undergo lumbar puncture.
DOI: 10.3233/JAD-170498
PubMed: 29125485